Mar 12, 2024 / 02:40PM GMT
David Reed Risinger - Leerink Partners LLC, Research Division - Senior MD & Senior Research Analyst
All right. Good morning, everyone. So my name is Dave Risinger. I cover diversified biopharmaceuticals for Leerink Partners, and it's very much my pleasure to welcome you to this session with Sanofi. And I am pleased that we're able to be joined by the 2 key leaders of the Immunology franchise at the company. So Shaju Backer to my immediate left, is the Global Head of the Immunology franchise; Naimish Patel is the Global Head of Development for Immunology and Inflammation. And so thank you both for being with us today.
Questions and Answers:
David Reed Risinger - Leerink Partners LLC, Research Division - Senior MD & Senior Research AnalystAnd it's actually great timing on the heels of AAD. And so I thought maybe you could start with just some comments on the momentum for the company and quick takeaways from AAD.
Shaju Backer - Sanofi - Global Head of Immunology Franchise
Sure. So Naimish, I might talk